Peter Brown,
Principal Investigator
Peter J. Brown is Project Manager, Epigenetics at the Structural Genomics Consortium, University of Toronto. He received his Ph.D. from the University of Sheffield and performed postdoctoral research at Indiana University with Philip Magnus culminating in the total synthesis of (-)-Pleiomutine, a bis-indole alkaloid. Prior to joining the SGC, Dr. Brown spent nineteen years at GlaxoSmithKline in various roles, most recently Section Head, Medicinal Chemistry, and was focused on the early Hit-ID phase of Drug Discovery and finding tool compounds for the Nuclear Receptor family of proteins. Dr. Brown’s research interests include using HTS, target-specific arrays, and fragment-based methods to discover probes for epigenetic targets.
|
|
|
